Form 4 for ACIU AC Immune SA
Accepted 2026-05-18 16:25:40 ET · period of report 2026-05-15 · accession 0001651625-26-000007 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-05-18 16:25 | 2026-05-15 | ACIU | Pfeifer Andrea | CEO, Dir | S - Sale | $2.79 | -10.0K | 3.82M | -0.3% | -$27.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Share | 2026-05-15 | S | D | 10,000 | $2.79 | 3,820,288 | D | — | — | (F1) The price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.75 to $2.825. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. (F2) Includes 1,921,005 common shares underlying outstanding restricted share units. |